Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology

Ganga Pharmaceuticals Limited

Healthcare › Pharmaceuticals & Biotechnology

₹12.50

at close · 8 Sept 2026

▲ 0.50 (+4.17%)

Next results in 4d Get alerts

Latest filings

Next results: Mon, 2 Nov · Financial Results

Tue, 27 OctBoard meeting to approve half-year financial results · Results
Tue, 13 OctRTA certificate for share dematerialization filed for Q2FY26 · Compliance
Sat, 26 SeptRe-appointment of Managing Director Mr. Bharat Brijmohan Sharma · Management Changes

All filings ↓

Ask Nexa about Ganga Pharmaceuticals Limited

Snapshot

What the business is, and whether it's a good one at a fair price.

A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹5 Cr over the trailing twelve months.

Market Cap

₹7 Cr

P / E (TTM)

37.9×

EV / EBITDA

—

Div Yield

—

Growth

3.6%▲

Revenue 5y CAGR

PAT — · EBITDA —

Quality

3.7%·

ROCE (5y median)

ROE — · margin —

Leverage

—·

Debt / Equity · borrowings not filed

Revenue FY21→FY26

1.2×▲

Revenue change

₹2 Cr → ₹3 Cr

Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures

P/E (TTM)#99/158

ROCE#143/183

Revenue growth#118/161

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Strengths

Nothing stands out in the filed numbers.

Concerns

Slow revenue growth — 4% a year over 5 years

Returns on capital 3.7% (5-year median)

#143 of 183 in Pharmaceuticals on the latest reported figures

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Governance

Is the board independent, clean and well-run?

Compliance

Did a company secretary sign off that it's clean?

Audit Report

What the auditor actually said — opinion, key audit matters, CARO clauses.

Earnings Call

What management said — and how it landed.

Investor Presentation

An AI read of the latest deck — verdict, KPIs, key slides and what it promised.

Events

Board meetings and results dates, upcoming and recent.

Reactions

How does the stock move after this company files?

Filings

The full disclosure feed.

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from Ganga Pharmaceuticals Limited's filed financials and exchange disclosures

What does Ganga Pharmaceuticals Limited do?

Ganga Pharmaceuticals Limited is a Pharmaceuticals & Biotechnology company listed on BSE.

Is Ganga Pharmaceuticals Limited expensive compared with its peers?

On trailing P/E, Ganga Pharmaceuticals Limited ranks 99 of 158 in Pharmaceuticals — cheaper than 38% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.

When are Ganga Pharmaceuticals Limited's next results?

Financial Results on Mon, 2 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track Ganga Pharmaceuticals Limited's announcements?

Every NSE and BSE filing by Ganga Pharmaceuticals Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.